ML design of enzyme therapies. Enzyme Design operates in Biotech; this dossier captures the Pre-Seed we participated in.
$6M round on a $10M Pre Priced Round with Amplify as the Lead SH committed $800,000, via StoryHouse Fund II, at a $16M valuation, in a $6M round, alongside Third Rock Ventures, Amplify Partners.
KH Notes: ___________ M&K with Aaron \### Round Status • Lawyers (Goodwin for Enzyme Co, Cooley for Amplify) exchanging drafts; currently stuck on drag-along rights • First draft shared from Goodwin to Cooley; Cooley reviewing, expected back by end of this week • Target close: April 24 or end of following week — strong preference to avoid slippi…
Source: Meeting Notes reczrWvQbwAsRYAjW
Elliot Hershberg is the partner at Amplify who is leading the Seed round for Enzyme Design. <https://www.amplifypartners.com/team/elliot-hershberg>
Source: Meeting Notes reclnbQfq3nMkFwJJ
Source: Meeting Notes recL6GCQXJaLb6jqR